• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡咯并[2,1-][1,2,4]三嗪的合成策略:抗病毒药物瑞德西韦的母体部分。

Synthetic strategies for pyrrolo[2,1-][1,2,4]triazine: the parent moiety of antiviral drug remdesivir.

作者信息

Rai Gaurav S, Maru Jayesh J

机构信息

Department of Chemistry, University School of Sciences, Gujarat University, Navrangpura, Ahmedabad, 380009 India.

出版信息

Chem Heterocycl Compd (N Y). 2020;56(12):1517-1522. doi: 10.1007/s10593-020-02844-9. Epub 2021 Jan 4.

DOI:10.1007/s10593-020-02844-9
PMID:33424029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7779642/
Abstract

This review summarizes diverse synthetic protocols for the preparation of pyrrolo[2,1-][1,2,4]triazine derivatives, covering literature sources from the past two decades. For effective representation, the synthetic methods toward the title compound are classified into six distinct categories: 1) synthesis from pyrrole derivatives, 2) synthesis bromohydrazone, 3) synthesis formation of triazinium dicyanomethylide, 4) multistep synthesis, 5) transition metal mediated synthesis, and 6) rearrangement of pyrrolooxadiazines. A brief outline of all optimized schemes is provided with relevant examples.

摘要

本综述总结了过去二十年来文献中用于制备吡咯并[2,1-][1,2,4]三嗪衍生物的各种合成方法。为了便于有效呈现,合成该标题化合物的方法分为六个不同类别:1)由吡咯衍生物合成;2)由溴腙合成;3)由三嗪二氰甲基化物形成合成;4)多步合成;5)过渡金属介导的合成;6)吡咯并恶二嗪的重排。文中提供了所有优化方案的简要概述及相关示例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/409ea07b290d/10593_2020_2844_Sch14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/3bda2c2309fa/10593_2020_2844_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/83eec4c6c77b/10593_2020_2844_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/8792ec532e2a/10593_2020_2844_Sch2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/4db7011c1b13/10593_2020_2844_Sch3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/03d287b262de/10593_2020_2844_Sch4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/7e148f21b27e/10593_2020_2844_Sch5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/8efedff3dcae/10593_2020_2844_Sch6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/28a7c8c89280/10593_2020_2844_Sch7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/690d07805515/10593_2020_2844_Sch8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/ffce4dfb732b/10593_2020_2844_Sch9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/6f6fb1d19471/10593_2020_2844_Sch10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/833267cf382b/10593_2020_2844_Sch11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/37ced69bf9b2/10593_2020_2844_Sch12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/1c13e0b5fe06/10593_2020_2844_Sch13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/409ea07b290d/10593_2020_2844_Sch14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/3bda2c2309fa/10593_2020_2844_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/83eec4c6c77b/10593_2020_2844_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/8792ec532e2a/10593_2020_2844_Sch2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/4db7011c1b13/10593_2020_2844_Sch3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/03d287b262de/10593_2020_2844_Sch4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/7e148f21b27e/10593_2020_2844_Sch5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/8efedff3dcae/10593_2020_2844_Sch6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/28a7c8c89280/10593_2020_2844_Sch7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/690d07805515/10593_2020_2844_Sch8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/ffce4dfb732b/10593_2020_2844_Sch9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/6f6fb1d19471/10593_2020_2844_Sch10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/833267cf382b/10593_2020_2844_Sch11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/37ced69bf9b2/10593_2020_2844_Sch12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/1c13e0b5fe06/10593_2020_2844_Sch13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5852/7779642/409ea07b290d/10593_2020_2844_Sch14_HTML.jpg

相似文献

1
Synthetic strategies for pyrrolo[2,1-][1,2,4]triazine: the parent moiety of antiviral drug remdesivir.吡咯并[2,1-][1,2,4]三嗪的合成策略:抗病毒药物瑞德西韦的母体部分。
Chem Heterocycl Compd (N Y). 2020;56(12):1517-1522. doi: 10.1007/s10593-020-02844-9. Epub 2021 Jan 4.
2
Facile and Scalable Methodology for the Pyrrolo[2,1-][1,2,4]triazine of Remdesivir.瑞德西韦的吡咯并[2,1-][1,2,4]三嗪的简便且可扩展的合成方法。
Org Process Res Dev. 2022 Jan 21;26(1):82-90. doi: 10.1021/acs.oprd.1c00071. Epub 2022 Jan 7.
3
Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy.吡咯并[2,1-f][1,2,4]三嗪:癌症治疗中一种有前景的用于靶向激酶的稠合杂环化合物。
Med Chem Res. 2022;31(1):1-25. doi: 10.1007/s00044-021-02819-1. Epub 2021 Nov 13.
4
Synthesis and Biological Evaluation of Pyrrolo[2,1-f][1,2,4]triazine C-Nucleosides with a Ribose, 2'-Deoxyribose, and 2',3'-Dideoxyribose Sugar Moiety.吡咯并[2,1-f][1,2,4]三嗪 C-核苷类似物的合成及生物评价,其糖部分为核糖、2'-脱氧核糖和 2',3'-二脱氧核糖。
ChemMedChem. 2018 Jan 8;13(1):97-104. doi: 10.1002/cmdc.201700657. Epub 2017 Dec 12.
5
Synthesis of pyrrolo[2,1-][1,2,4]triazin-4(3)-ones: Rearrangement of pyrrolo[1,2-][1,3,4]oxadiazines and regioselective intramolecular cyclization of 1,2-biscarbamoyl-substituted 1-pyrroles.吡咯并[2,1-][1,2,4]三嗪-4(3)-酮的合成:吡咯并[1,2-][1,3,4]恶二嗪的重排及1,2-双氨基甲酰基取代的1-吡咯的区域选择性分子内环化反应
Beilstein J Org Chem. 2016 Aug 9;12:1780-1787. doi: 10.3762/bjoc.12.168. eCollection 2016.
6
Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistry. privileged scaffolds 或 promiscuous binders:吡咯并[2,1-f][1,2,4]三嗪及相关桥头氮杂环在药物化学中的一瞥。
Curr Pharm Des. 2013;19(8):1528-48.
7
Anti-norovirus activity of C7-modified 4-amino-pyrrolo[2,1-f][1,2,4]triazine C-nucleosides.C7 修饰的 4-氨基-吡咯并[2,1-f][1,2,4]三嗪 C-核苷的抗诺如病毒活性。
Eur J Med Chem. 2020 Jun 1;195:112198. doi: 10.1016/j.ejmech.2020.112198. Epub 2020 Mar 7.
8
Synthesis of carbon-11-labeled 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine derivatives as new potential PET tracers for imaging of p38α mitogen-activated protein kinase.碳-11标记的4-(苯胺基)-吡咯并[2,1-f][1,2,4]三嗪衍生物的合成作为用于p38α丝裂原活化蛋白激酶成像的新型潜在正电子发射断层显像剂
Bioorg Med Chem Lett. 2014 Aug 15;24(16):3700-5. doi: 10.1016/j.bmcl.2014.07.017. Epub 2014 Jul 12.
9
Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo[2,1-f][1,2,4]triazine derivatives.设计、合成及吡咯并[2,1-f][1,2,4]三嗪衍生物的抗增殖活性评价。
Bioorg Med Chem Lett. 2020 Jun 15;30(12):127194. doi: 10.1016/j.bmcl.2020.127194. Epub 2020 Apr 13.
10
Expanding Access to Remdesivir via an Improved Pyrrolotriazine Synthesis: Supply Centered Synthesis.通过改进的吡咯并三嗪合成扩大瑞德西韦的可及性:以供应为中心的合成
Org Lett. 2020 Oct 2;22(19):7656-7661. doi: 10.1021/acs.orglett.0c02848. Epub 2020 Sep 15.

引用本文的文献

1
Indazole - an emerging privileged scaffold: synthesis and its biological significance.吲唑——一种新兴的优势骨架:合成及其生物学意义
RSC Med Chem. 2025 Aug 19. doi: 10.1039/d5md00336a.
2
Efficient Approaches to the Design of Six-Membered Polyazacyclic Compounds-Part 1: Aromatic Frameworks.六元聚氮杂环化合物设计的有效方法——第1部分:芳香骨架
Molecules. 2025 Aug 4;30(15):3264. doi: 10.3390/molecules30153264.
3
The activity of pyrazolo[4,3-][1,2,4]triazine and pyrazolo[4,3-]tetrazolo[1,5-][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures.

本文引用的文献

1
Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo[2,1-f][1,2,4]triazine derivatives.设计、合成及吡咯并[2,1-f][1,2,4]三嗪衍生物的抗增殖活性评价。
Bioorg Med Chem Lett. 2020 Jun 15;30(12):127194. doi: 10.1016/j.bmcl.2020.127194. Epub 2020 Apr 13.
2
Anti-norovirus activity of C7-modified 4-amino-pyrrolo[2,1-f][1,2,4]triazine C-nucleosides.C7 修饰的 4-氨基-吡咯并[2,1-f][1,2,4]三嗪 C-核苷的抗诺如病毒活性。
Eur J Med Chem. 2020 Jun 1;195:112198. doi: 10.1016/j.ejmech.2020.112198. Epub 2020 Mar 7.
3
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
吡唑并[4,3 - ][1,2,4]三嗪及吡唑并[4,3 - ]四唑并[1,5 - ][1,2,4]三嗪磺酰胺衍生物在单层及球体乳腺癌细胞培养中的活性
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2343352. doi: 10.1080/14756366.2024.2343352. Epub 2024 May 3.
4
Evolution of the Synthesis of Remdesivir. Classical Approaches and Most Recent Advances.瑞德西韦的合成进展。经典方法与最新进展。
ACS Omega. 2021 Jul 23;6(30):19356-19363. doi: 10.1021/acsomega.1c03082. eCollection 2021 Aug 3.
瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒(2019 - 新冠病毒)。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
4
Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2.探索新型吡咯并[2,1-f][1,2,4]三嗪衍生物作为 c-Met/VEGFR-2 的双重抑制剂以提高抗癌疗效。
Eur J Med Chem. 2018 Oct 5;158:814-831. doi: 10.1016/j.ejmech.2018.09.050. Epub 2018 Sep 18.
5
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.用于治疗埃博拉病毒及其他新出现病毒的吡咯并[2,1-f][三嗪-4-氨基]腺嘌呤C-核苷(GS-5734)的磷酰胺酯前药的发现与合成
J Med Chem. 2017 Mar 9;60(5):1648-1661. doi: 10.1021/acs.jmedchem.6b01594. Epub 2017 Feb 14.
6
Synthesis of pyrrolo[2,1-][1,2,4]triazin-4(3)-ones: Rearrangement of pyrrolo[1,2-][1,3,4]oxadiazines and regioselective intramolecular cyclization of 1,2-biscarbamoyl-substituted 1-pyrroles.吡咯并[2,1-][1,2,4]三嗪-4(3)-酮的合成:吡咯并[1,2-][1,3,4]恶二嗪的重排及1,2-双氨基甲酰基取代的1-吡咯的区域选择性分子内环化反应
Beilstein J Org Chem. 2016 Aug 9;12:1780-1787. doi: 10.3762/bjoc.12.168. eCollection 2016.
7
Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modifications.白细胞介素-1受体相关激酶4的N-(1H-吡唑-4-基)甲酰胺抑制剂的鉴定:双环核心修饰
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5384-8. doi: 10.1016/j.bmcl.2015.09.028. Epub 2015 Sep 11.
8
Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase.作为间变性淋巴瘤激酶抑制剂的吡咯并[2,1-f][1,2,4]三嗪的哌啶-3,4-二醇和哌啶-3-醇衍生物
Bioorg Med Chem Lett. 2015 Mar 1;25(5):1047-52. doi: 10.1016/j.bmcl.2015.01.019. Epub 2015 Jan 17.
9
Synthesis of carbon-11-labeled 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine derivatives as new potential PET tracers for imaging of p38α mitogen-activated protein kinase.碳-11标记的4-(苯胺基)-吡咯并[2,1-f][1,2,4]三嗪衍生物的合成作为用于p38α丝裂原活化蛋白激酶成像的新型潜在正电子发射断层显像剂
Bioorg Med Chem Lett. 2014 Aug 15;24(16):3700-5. doi: 10.1016/j.bmcl.2014.07.017. Epub 2014 Jul 12.
10
Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.作为潜在新型抗丙型肝炎病毒药物的C-核苷的发现与合成
ACS Med Chem Lett. 2014 Apr 10;5(6):679-84. doi: 10.1021/ml500077j. eCollection 2014 Jun 12.